Gene therapy, targeting conditions like sickle cell anemia and hemophilia, was the largest application in the gene delivery technologies market in 2023. With over 1,500 trials in progress, its impact is far-reaching. Cell therapy, particularly for cancer and autoimmune diseases, is the fastest-growing segment due to promising clinical outcomes. Emergen Research has recently published a detailed...